• Je něco špatně v tomto záznamu ?

Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics

Z. Koledova, J. Sumbal, A. Rabata, G. de La Bourdonnaye, R. Chaloupkova, B. Hrdlickova, J. Damborsky, V. Stepankova,

. 2019 ; 7 (-) : 331. [pub] 20191212

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005397

Fibroblast growth factor 2 (FGF2) plays important roles in tissue development and repair. Using heparan sulfates (HS)/heparin as a cofactor, FGF2 binds to FGF receptor (FGFR) and induces downstream signaling pathways, such as ERK pathway, that regulate cellular behavior. In most cell lines, FGF2 signaling displays biphasic dose-response profile, reaching maximal response to intermediate concentrations, but weak response to high levels of FGF2. Recent reports demonstrated that the biphasic cellular response results from competition between binding of FGF2 to HS and FGFR that impinge upon ERK signaling dynamics. However, the role of HS/heparin in FGF signaling has been controversial. Several studies suggested that heparin is not required for FGF-FGFR complex formation and that the main role of heparin is to protect FGF from degradation. In this study, we investigated the relationship between FGF2 stability, heparin dependence and ERK signaling dynamics using FGF2 variants with increased thermal stability (FGF2-STABs). FGF2-STABs showed higher efficiency in induction of FGFR-mediated proliferation, lower affinity to heparin and were less dependent on heparin than wild-type FGF2 (FGF2-wt) for induction of FGFR-mediated mitogenic response. Interestingly, in primary mammary fibroblasts, FGF2-wt displayed a sigmoidal dose-response profile, while FGF2-STABs showed a biphasic response. Moreover, at low concentrations, FGF2-STABs induced ERK signaling more potently and displayed a faster dynamics of full ERK activation and higher amplitudes of ERK signaling than FGF2-wt. Our results suggest that FGF2 stability and heparin dependence are important factors in FGF-FGFR signaling complex assembly and ERK signaling dynamics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005397
003      
CZ-PrNML
005      
20200528105828.0
007      
ta
008      
200511s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fcell.2019.00331 $2 doi
035    __
$a (PubMed)31921844
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Koledova, Zuzana $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czechia. International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia.
245    10
$a Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics / $c Z. Koledova, J. Sumbal, A. Rabata, G. de La Bourdonnaye, R. Chaloupkova, B. Hrdlickova, J. Damborsky, V. Stepankova,
520    9_
$a Fibroblast growth factor 2 (FGF2) plays important roles in tissue development and repair. Using heparan sulfates (HS)/heparin as a cofactor, FGF2 binds to FGF receptor (FGFR) and induces downstream signaling pathways, such as ERK pathway, that regulate cellular behavior. In most cell lines, FGF2 signaling displays biphasic dose-response profile, reaching maximal response to intermediate concentrations, but weak response to high levels of FGF2. Recent reports demonstrated that the biphasic cellular response results from competition between binding of FGF2 to HS and FGFR that impinge upon ERK signaling dynamics. However, the role of HS/heparin in FGF signaling has been controversial. Several studies suggested that heparin is not required for FGF-FGFR complex formation and that the main role of heparin is to protect FGF from degradation. In this study, we investigated the relationship between FGF2 stability, heparin dependence and ERK signaling dynamics using FGF2 variants with increased thermal stability (FGF2-STABs). FGF2-STABs showed higher efficiency in induction of FGFR-mediated proliferation, lower affinity to heparin and were less dependent on heparin than wild-type FGF2 (FGF2-wt) for induction of FGFR-mediated mitogenic response. Interestingly, in primary mammary fibroblasts, FGF2-wt displayed a sigmoidal dose-response profile, while FGF2-STABs showed a biphasic response. Moreover, at low concentrations, FGF2-STABs induced ERK signaling more potently and displayed a faster dynamics of full ERK activation and higher amplitudes of ERK signaling than FGF2-wt. Our results suggest that FGF2 stability and heparin dependence are important factors in FGF-FGFR signaling complex assembly and ERK signaling dynamics.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sumbal, Jakub $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czechia. International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia.
700    1_
$a Rabata, Anas $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czechia.
700    1_
$a de La Bourdonnaye, Gabin $u Enantis, Brno, Czechia. Loschmidt Laboratories, RECETOX and Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Chaloupkova, Radka $u Enantis, Brno, Czechia. Loschmidt Laboratories, RECETOX and Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Hrdlickova, Barbara $u Enantis, Brno, Czechia.
700    1_
$a Damborsky, Jiri $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia. Enantis, Brno, Czechia. Loschmidt Laboratories, RECETOX and Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Stepankova, Veronika $u Enantis, Brno, Czechia.
773    0_
$w MED00186212 $t Frontiers in cell and developmental biology $x 2296-634X $g Roč. 7, č. - (2019), s. 331
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31921844 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200528105825 $b ABA008
999    __
$a ind $b bmc $g 1524327 $s 1095452
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 7 $c - $d 331 $e 20191212 $i 2296-634X $m Frontiers in cell and developmental biology. $n Front Cell Dev Biol $x MED00186212
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace